[In vitro effectiveness of new antiviral substances. 2. studies with enteroviruses and rhinovirus lB].
The antiviral efficacy of several compounds was demonstrated against Coxsackie viruses type A9, B1, B3, B4 and B5, echoviruses type 6, 11, 30, and 33, attenuated polioviruses and rhinovirus 1B. In one-step growth cycle experiments virus multiplication was clearly inhibited by application of the compounds immediately after virus adsorption.
D000998:Antiviral Agents / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D004770:Enterovirus / Q000187:drug effects*; D029822:Enterovirus B, Human / Q000187:drug effects; D008826:Microbial Sensitivity Tests / Q000379:methods; D017955:Poliovirus / Q000187:drug effects; D012229:Rhinovirus / Q000187:drug effects*
D000998:Antiviral Agents
Uber die In-vitro-Wirksamkeit neuer antiviraler Substanzen. 2. Mitteilung. Untersuchungen mit Enteroviren und Rhinovirus 1B.